Literature DB >> 19428849

Estradiol-induced vaginal mucus inhibits antigen penetration and CD8(+) T cell priming in response to intravaginal immunization.

Matthew M Seavey1, Tim R Mosmann.   

Abstract

Although vaginal immunization has been explored as a strategy to induce mucosal immunity in the female reproductive tract, this site displays unique immunological features that probably evolved to inhibit anti-paternal T cell responses after insemination to allow successful pregnancy. We previously demonstrated that estradiol, which induces an estrus-like state, prevented CD8(+) T cell priming during intravaginal immunization of mice. We now show that estradiol prevented antigen loading of vaginal antigen presenting cells (APCs) after intravaginal immunization. Histological examination confirmed that estradiol prevented penetration of peptide antigen into the vaginal wall. Removal of the estradiol-induced mucus barrier by mucinase partially restored antigen loading of vaginal APC and CD8(+) T cell proliferation in vivo. The estradiol-induced mucus barrier may thus prevent exposure to antigens delivered intravaginally, supplementing additional estradiol-dependent mechanism(s) that inhibit CD8(+) T cell priming after insemination or vaginal vaccination.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428849      PMCID: PMC2952928          DOI: 10.1016/j.vaccine.2009.02.025

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  35 in total

1.  PGE2 suppresses mitogen-induced Ca2+ mobilization in T cells.

Authors:  M A Choudhry; P E Hockberger; M M Sayeed
Journal:  Am J Physiol       Date:  1999-12

Review 2.  The role of semen in induction of maternal immune tolerance to pregnancy.

Authors:  S A Robertson; D J Sharkey
Journal:  Semin Immunol       Date:  2001-08       Impact factor: 11.130

Review 3.  Control of the immunological environment of the uterus.

Authors:  S A Robertson
Journal:  Rev Reprod       Date:  2000-09

Review 4.  Microbicides and other topical strategies to prevent vaginal transmission of HIV.

Authors:  Michael M Lederman; Robin E Offord; Oliver Hartley
Journal:  Nat Rev Immunol       Date:  2006-05       Impact factor: 53.106

Review 5.  A model T-cell receptor system for studying memory T-cell development.

Authors:  Jianzhu Chen; Herman N Eisen; David M Kranz
Journal:  Microbes Infect       Date:  2003-03       Impact factor: 2.700

6.  Vaginal mucosa serves as an inductive site for tolerance.

Authors:  C A Black; L C Rohan; M Cost; S C Watkins; R Draviam; S Alber; R P Edwards
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

7.  Antigen presentation by vaginal cells: role of TGFbeta as a mediator of estradiol inhibition of antigen presentation.

Authors:  Charles R Wira; Marcie A Roche; Richard M Rossoll
Journal:  Endocrinology       Date:  2002-08       Impact factor: 4.736

8.  Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle.

Authors:  Pamela A Kozlowski; Selvi B Williams; Rebecca M Lynch; Timothy P Flanigan; Rosalyn R Patterson; Susan Cu-Uvin; Marian R Neutra
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

9.  Influence of the murine oestrous cycle on the induction of mucosal immunity.

Authors:  Christine M Gockel; Shisan Bao; Michael K Holland; Kenneth W Beagley
Journal:  Am J Reprod Immunol       Date:  2003-11       Impact factor: 3.886

10.  Oestradiol regulation of antigen presentation by uterine stromal cells: role of transforming growth factor-beta production by epithelial cells in mediating antigen-presenting cell function.

Authors:  Charles R Wira; Richard M Rossoll
Journal:  Immunology       Date:  2003-07       Impact factor: 7.397

View more
  11 in total

Review 1.  Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites.

Authors:  Mevyn Nizard; Mariana O Diniz; Helene Roussel; Thi Tran; Luis Cs Ferreira; Cecile Badoual; Eric Tartour
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  Mouse strain-dependent differences in estrogen sensitivity during vaginal candidiasis.

Authors:  Paolo Mosci; Donatella Pietrella; Giovanni Ricci; Neelam Pandey; Claudia Monari; Eva Pericolini; Elena Gabrielli; Stefano Perito; Francesco Bistoni; Anna Vecchiarelli
Journal:  Mycopathologia       Date:  2012-10-07       Impact factor: 2.574

3.  Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus.

Authors:  Laura M Ensign; Benjamin C Tang; Ying-Ying Wang; Terence A Tse; Timothy Hoen; Richard Cone; Justin Hanes
Journal:  Sci Transl Med       Date:  2012-06-13       Impact factor: 17.956

4.  Characterization of a Hormone-Responsive Organotypic Human Vaginal Tissue Model: Morphologic and Immunologic Effects.

Authors:  Seyoum Ayehunie; Ayesha Islam; Chris Cannon; Timothy Landry; Jeffrey Pudney; Mitchell Klausner; Deborah J Anderson
Journal:  Reprod Sci       Date:  2015-02-11       Impact factor: 3.060

Review 5.  Towards the future exploration of mucosal mRNA vaccines against emerging viral diseases; lessons from existing next-generation mucosal vaccine strategies.

Authors:  Sodiq A Hameed; Stephane Paul; Giann Kerwin Y Dellosa; Dolores Jaraquemada; Muhammad Bashir Bello
Journal:  NPJ Vaccines       Date:  2022-06-28       Impact factor: 9.399

6.  Ex vivo characterization of particle transport in mucus secretions coating freshly excised mucosal tissues.

Authors:  Laura M Ensign; Andreas Henning; Craig S Schneider; Katharina Maisel; Ying-Ying Wang; Marc D Porosoff; Richard Cone; Justin Hanes
Journal:  Mol Pharm       Date:  2013-05-23       Impact factor: 4.939

Review 7.  Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection.

Authors:  Blaise Corthésy; Gilles Bioley
Journal:  Front Immunol       Date:  2018-03-07       Impact factor: 7.561

Review 8.  Needle-Free Immunization with Chitosan-Based Systems.

Authors:  Bijay Singh; Sushila Maharjan; Princy Sindurakar; Ki-Hyun Cho; Yun-Jaie Choi; Chong-Su Cho
Journal:  Int J Mol Sci       Date:  2018-11-19       Impact factor: 5.923

9.  Vaginal immunization to elicit primary T-cell activation and dissemination.

Authors:  Elena Pettini; Gennaro Prota; Annalisa Ciabattini; Alessandro Boianelli; Fabio Fiorino; Gianni Pozzi; Antonio Vicino; Donata Medaglini
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

10.  Simultaneous Subcutaneous and Intranasal Administration of a CAF01-Adjuvanted Chlamydia Vaccine Elicits Elevated IgA and Protective Th1/Th17 Responses in the Genital Tract.

Authors:  Jeanette Erbo Wern; Maria Rathmann Sorensen; Anja Weinreich Olsen; Peter Andersen; Frank Follmann
Journal:  Front Immunol       Date:  2017-05-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.